Elaine Watson

Novameat's series A funds will be used to support entry into new markets, expand the product portfolio, scale production, and accelerate R&D.

Proprietary texturizing tech has ‘significantly lower energy requirements' than high and low moisture extrusion

GLP-1 drugs are “the most effective drugs we've ever invented for obesity,” but they “aren't going to cure it,” says one public health expert

Ex-Novozymes exec Peter Rosholm has acquired the assets of bankrupt biomanufacturing startups Solar Biotech and Noblegen.

GLP-1 drugs are “the most effective drugs we've ever invented for obesity treatment,” but they “aren't going to cure the obesity epidemic,” says one public health expert.

Juicy Marbles is planning a move into US retail in 2025 and is developing a new more accessible product to broaden its consumer base.

ReScale —a Boston-based startup led by ex-Trader Joe's exec Julia Megson—has emerged from stealth after raising a $2.3 million round led by Baukunst

Pairwise , a startup pioneering gene editing in plants, has closed a $40m series C funding round and formed a five-year joint venture collaboration

A vaccine is by far the most cost-effective way to tackle livestock methane emissions at scale within a reasonable timeframe, claims ArkeaBio

Multiple strategies are being explored to address methane emissions from belching livestock from cattle breeding programs and feed additives to editing the genes of the microbes in the rumen.